Work

Clinical Outcomes Following Mandatory Switching to an Adalimumab Biosimilar in Patients with Psoriasis: A Real-world Single-centre Experience

Year: 2026

Type: article

Source: Acta Dermato Venereologica

DOI: 10.2340/actadv.v106.adv-2026-0624

Authors: Mariá Simas D’Aquino, Roberto Moreira Amorim Filho, Gustavo Moreira Amorim

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,725

OpenAlex ID: W7225080068

FWCI:

Cites: 6

Cited by:

Related to: 10